Latest Bio Stimulants News

Page 1 of 3
Skin Elements has converted its New Zealand Farmlands agreement into a first NZ$150,000 ECO-Nurture delivery, while A$900,000 in placement proceeds lifted quarter-end cash to A$1.455 million. The commercial progress comes alongside a cost review and a regulatory hurdle still standing between the company and broader national sales.
Ada Torres
Ada Torres
29 Oct 2026
Skin Elements has secured firm commitments for a A$700,000 placement to fund working capital and commercialisation across its natural biotechnology portfolio. The raising includes 318.2 million free-attaching options, making shareholder approval and future dilution important next steps.
Ada Torres
Ada Torres
27 Oct 2026
Ocean Sciences delivered a sharp increase in seaweed revenue during FY2026, but the audited report also records a A$1.612 million continuing-operations loss, A$2.319 million operating cash outflow and material uncertainty over its ability to continue as a going concern. The renamed ASX-listed group is now seeking up to A$3 million while building out its Indonesian platform.
Ada Torres
Ada Torres
29 Sept 2026
Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.
Ada Torres
Ada Torres
25 Aug 2026
Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.
Ada Torres
Ada Torres
31 July 2026
Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.
Ada Torres
Ada Torres
26 June 2026
BPH Global has secured a key coastal site in South Sulawesi to boost its seaweed cultivation and processing capabilities, underpinning its vertical integration strategy across food and bio stimulant markets.
Ada Torres
Ada Torres
22 Apr 2026
Skin Elements Limited reported a $4.01 million loss for the half-year ending December 2025, alongside a 41% revenue drop, while securing $2.5 million in fresh capital to advance its proprietary SE Formula biotechnology products.
Ada Torres
Ada Torres
27 Feb 2026
BPH Global has reported record sales in its Indonesian seaweed operations alongside completing a $1.1 million capital raise and advancing promising R&D projects. The company is scaling its trading platform and expanding into bio-stimulants and wellness products as it enters 2026.
Ada Torres
Ada Torres
30 Jan 2026
Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.
Ada Torres
Ada Torres
11 Dec 2025
Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.
Ada Torres
Ada Torres
4 Dec 2025
Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.
Ada Torres
Ada Torres
17 Nov 2025

Browse the archive

Full archive